Australia secures new COVID-fighting drug

By Georgie Moore
Updated October 4 2021 - 11:35am, first published 11:30am
Trials suggest Merck's new antiviral drug reduces COVID hospitalisations and deaths by around half.

Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and hospitalisations.

Advertisement

Ad

Advertisement

Ad

Advertisement

Ad